Table 1 Comparison of demographic data and comorbidities between APAP group and control subjects
Variable | APAP group (n = 3235) | Control group (n = 9705) | p Value |
|---|---|---|---|
Age at index date (years) | 31.3 ± 13.4 | 31.3 ± 13.4 | >0.999 |
Age at index date (years) | |||
0–20 | 385 (11.9) | 1155 (11.9) | >0.999 |
21–39 | 2235 (69.1) | 6705 (69.1) | |
40–64 | 489 (15.1) | 1467 (15.1) | |
≥ 65 | 126 (3.9) | 378 (3.9) | |
Sex | |||
Male | 895 (27.7) | 2685 (27.7) | >0.999 |
Female | 2340 (72.3) | 7020 (72.3) | |
Comorbiditya | |||
DM | 124 (3.8) | 313 (3.2) | 0.097 |
CAD | 149 (4.6) | 317 (3.3) | <0.001 |
Stroke | 84 (2.6) | 137 (1.4) | <0.001 |
HTN | 248 (7.7) | 666 (6.9) | 0.122 |
Liver disease | 396 (12.2) | 952 (9.8) | <0.001 |
Renal disease | 308 (9.5) | 633 (6.5) | <0.001 |
Mental Disorder | 1139 (35.2) | 1409 (14.5) | <0.001 |
Cancer | 75 (2.3) | 145 (1.5) | 0.002 |
Geographic region | |||
North | 3013 (93.1) | 8876 (91.5) | 0.019 |
Center | 92 (2.8) | 315 (3.3) | |
South | 121 (3.7) | 479 (4.9) | |
East | 9 (0.3) | 35 (0.4) | |
Monthly income | |||
NTD ≤ 15,840 | 1655 (51.2) | 3509 (36.2) | <0.001 |
NTD 15841–25,000 | 1152 (35.6) | 3975 (41.0) | |
NTD ≥ 25,001 | 428 (13.2) | 2221 (22.9) | |